What is Biohaven's R&D?

Biohaven (BHVN) reported R&D of $103.83M in Q1 2026.

How has Biohaven's R&D changed year-over-year?

Biohaven's R&D decreased by 44.7% year-over-year, from $187.58M to $103.83M.

What is the long-term trend for Biohaven's R&D?

Over 3 years (2022 to 2025), Biohaven's R&D has grown at a 13.3% compound annual growth rate (CAGR), from $437.07M to $635.07M.

Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.

Biohaven BHVN R&D

R&D at other companies

Eli LillyLLY

$3.51B+28.4%

Xenon PharmaceuticalsXENE

$88.51M+44.6%

Rapport Therapeutics, Inc.RAPP

$32.72M+67.2%

Vir Biotechnology, Inc.VIR

$108.92M-8.2%

uniQureQURE

$29.18M-19.3%

Protagonist TherapeuticsPTGX

$46.74M+30.2%

Other financials

Income statement

See full

Operating income-$130.4M+41.1%

Net income-$130.5M+41.1%

EPS (diluted)-$0.88+59.4%

Balance sheet

See full

Cash & equivalents$277.1M+170%

Total debt$286.2M+706%

Total equity$129.5M-50.1%

Total assets$466.4M+1.6%

Cash flow

See full

Operating cash flow-$149.9M+9.2%

CapEx--100%

Free cash flow-$149.9M+9.5%

Valuation

See full

Market cap$2.23B-48.1%

Enterprise value$2.23B-46.3%

Returns & leverage

See full

Return on equity-333%+17.9pp

Debt / equity2.2×+2.1×

Current ratio7.4×+5.1×

Where this comes from

Reported directly by Biohaven in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: Biohaven’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Biohaven's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Biohaven's R&D?: Biohaven (BHVN) reported R&D of $103.83M in Q1 2026.
How has Biohaven's R&D changed year-over-year?: Biohaven's R&D decreased by 44.7% year-over-year, from $187.58M to $103.83M.
What is the long-term trend for Biohaven's R&D?: Over 3 years (2022 to 2025), Biohaven's R&D has grown at a 13.3% compound annual growth rate (CAGR), from $437.07M to $635.07M.
What does R&D mean?: Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.